Actuate Therapeutics, Inc. (ACTU)

2.265 -0.36 (-13.55%) USD  |  NASDAQ  |  Apr 21, 16:00
2.265 0.00 (0.00%) After-Hours: 16:12
More

Actuate Therapeutics EPS Diluted (Quarterly) : -0.1959 for Dec. 31, 2025

EPS Diluted (Quarterly) Chart

View EPS Diluted (Quarterly) for ACTU.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View EPS Diluted (Quarterly) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

EPS Diluted (Quarterly) Range, Past 5 Years

View EPS Diluted (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

EPS Diluted (Quarterly) Benchmarks

View EPS Diluted (Quarterly) Benchmarks
Start Trial
ACADIA Pharmaceuticals, Inc. 1.596
Agenus, Inc. -0.301
Alnylam Pharmaceuticals, Inc. 1.368
Savara, Inc. -0.1341
Arrowhead Pharmaceuticals, Inc. 0.219

EPS Diluted (Quarterly) Related Metrics

Net Income (Quarterly) -4.554M
Total Expenses (Quarterly) 4.554M
Enterprise Value 49.37M
Earnings Yield -47.48%
Normalized Earnings Yield -47.48